News

Dechra Pharmaceuticals Limited (Dechra) today announces the appointment of a new North American President

Laura Olsen will join Dechra as the new President, of North America, effective from the 9 September, bringing a wealth of experience in animal and human health, having previously worked at Zoetis, Pfizer, and Novartis.

Dechra Pharmaceuticals Limited (Dechra) announces upcoming acquisition of Invetx, in line with long term strategy to be an innovation leader in companion animal health

Invetx specialises in developing protein-based therapeutics for chronic conditions in companion animals, with a focus on monoclonal antibodies (mAbs). Its proprietary biotechnology innovation platform combines industry leading technologies to develop species specific and half-life extended mAbs that are longer lasting than currently available products, effective, safe and affordable.

FoodScience®, LLC, and Dechra Veterinary Products Inc. are pleased to announce that Dechra will be the exclusive veterinary distributor of VetriScience Legacy Products in Canada.

Dechra announces it has agreed to acquire Piedmont Animal Health, Inc.

Dechra (LSE: DPH) today announces it has agreed to acquire Piedmont Animal Health, Inc ("Piedmont"). Piedmont specializes in developing novel and differentiated products for the companion animal market and has a strong development track record. Piedmont specializes in developing novel and differentiated companion animal products ("CAP") with significant growth potential. Originally founded in 2001 in Greensboro, North Carolina, it has a long and successful track record of product development including major brands launched by multi-national animal health companies. Piedmont employs a development team of 19 people, increasing Dechra's scientific and regulatory capabilities.

Dechra announces it has agreed to acquire Piedmont Animal Health, Inc.

Dechra (LSE: DPH) today announces it has agreed to acquire Piedmont Animal Health, Inc ("Piedmont"). Piedmont specializes in developing novel and differentiated products for the companion animal market and has a strong development track record. Piedmont specializes in developing novel and differentiated companion animal products ("CAP") with significant growth potential. Originally founded in 2001 in Greensboro, North Carolina, it has a long and successful track record of product development including major brands launched by multi-national animal health companies. Piedmont employs a development team of 19 people, increasing Dechra's scientific and regulatory capabilities.

Dechra Announces VOHC Acceptance for Water Additive

Dechra Veterinary Products is pleased to announce that its VETRADENT® Liquid Water Additive has received the seal of acceptance to Help Control Tartar from the Veterinary Oral Health Council (VOHC). The seal has been granted for dogs after properly demonstrating both safety and efficacy.

Dechra Announces VOHC Acceptance for Water Additive

Dechra Veterinary Products is pleased to announce that its VETRADENT® Liquid Water Additive has received the seal of acceptance to Help Control Tartar from the Veterinary Oral Health Council (VOHC). The seal has been granted for dogs after properly demonstrating both safety and efficacy.

Taking steps today for a greener tomorrow

Dechra is working on making a difference through sustainable improvements in global animal health and welfare. As such, we created a guide with tips to help Veterinarians and their teams diminish their global impact on the environment. If you are a Veterinarian and would like more information, please contact your Dechra representative

Taking steps today for a greener tomorrow

Dechra is working on making a difference through sustainable improvements in global animal health and welfare. As such, we created a guide with tips to help Veterinarians and their teams diminish their global impact on the environment. If you are a Veterinarian and would like more information, please contact your Dechra representative

Dechra proudly introduces Mirataz: Veterinary licensed transdermal medication for feline weight control

Unintended weight loss is the #3 reason for pet owners to bring their cat to the veterinarian. Controlling rapid weight loss is critical, and to date has depended on off-label use of oral human medications, which can be difficult to administer and dose accurately.